• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西班牙穆尔西亚的镰状细胞病新生儿筛查项目。

A Newborn Screening Program for Sickle Cell Disease in Murcia (Spain).

作者信息

Sánchez-Villalobos María, Campos Baños Eulalia, Juan Fita María Jesús, Egea Mellado José María, Gonzalez Gallego Inmaculada, Beltrán Videla Asunción, Berenguer Piqueras Mercedes, Bermúdez Cortés Mar, Moraleda Jiménez José María, Guillen Navarro Encarna, Salido Fierrez Eduardo, Pérez-Oliva Ana B

机构信息

Hematology Service, Virgen de la Arrixaca University Hospital, 30120 Murcia, Spain.

Biomedical Research Institute of Murcia (IMIB), 30003 Murcia, Spain.

出版信息

Int J Neonatal Screen. 2023 Oct 10;9(4):55. doi: 10.3390/ijns9040055.

DOI:10.3390/ijns9040055
PMID:37873846
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10594431/
Abstract

Sickle cell disease (SCD) is an inherited autosomal recessive hemoglobin disorder caused by the presence of hemoglobin S, a mutant abnormal hemoglobin caused by a nucleotide change in codon 6 of the β-globin chain gene. SCD involves a chronic inflammatory state, exacerbated during vaso-occlusive crises, which leads to end-organ damage that occurs throughout the lifespan. SCD is associated with premature mortality in the first years of life. The process of sickling provokes asplenia in the first years of life with an increased risk of infection by encapsulated germs. These complications can be life-threatening and require early diagnosis and management. The most important interventions recommend an early diagnosis of SCD to ensure that affected newborns receive immediate care to reduce mortality and morbidity. The newborn screening program in the region of Murcia for SCD began in March 2016. We aimed to determine the incidence of sickle cell anemia and other structural hemoglobinopathies in the neonatal population of the region of Murcia, an area of high migratory stress, and to systematically assess the benefit of newborn screening for SCD, leading to earlier treatment, as well as to offer genetic counseling to all carriers. The prevalence of SCD in our region is similar to others in Spain, except for Catalonia and Madrid. The newborns with confirmed diagnoses of SCD received early attention, and all the carriers received genetic counseling.

摘要

镰状细胞病(SCD)是一种遗传性常染色体隐性血红蛋白疾病,由血红蛋白S的存在引起,血红蛋白S是一种由β - 珠蛋白链基因第6密码子的核苷酸变化导致的突变异常血红蛋白。SCD涉及一种慢性炎症状态,在血管闭塞性危机期间会加剧,这会导致终末器官损伤,这种损伤在整个生命周期中都会发生。SCD与生命最初几年的过早死亡有关。镰变过程在生命的最初几年会引发脾切除,增加被包膜菌感染的风险。这些并发症可能危及生命,需要早期诊断和管理。最重要的干预措施建议对SCD进行早期诊断,以确保受影响的新生儿能立即得到护理,从而降低死亡率和发病率。穆尔西亚地区针对SCD的新生儿筛查项目于2016年3月启动。我们旨在确定穆尔西亚地区新生儿人群中镰状细胞贫血和其他结构性血红蛋白病的发病率,该地区是一个移民压力较大的地区,并系统评估新生儿SCD筛查的益处,从而实现更早治疗,同时为所有携带者提供遗传咨询。我们地区SCD的患病率与西班牙其他地区相似,加泰罗尼亚和马德里除外。确诊为SCD的新生儿得到了早期关注,所有携带者都接受了遗传咨询。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4488/10594431/b67a4044660c/IJNS-09-00055-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4488/10594431/2312f9b95fe2/IJNS-09-00055-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4488/10594431/b67a4044660c/IJNS-09-00055-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4488/10594431/2312f9b95fe2/IJNS-09-00055-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4488/10594431/b67a4044660c/IJNS-09-00055-g002.jpg

相似文献

1
A Newborn Screening Program for Sickle Cell Disease in Murcia (Spain).西班牙穆尔西亚的镰状细胞病新生儿筛查项目。
Int J Neonatal Screen. 2023 Oct 10;9(4):55. doi: 10.3390/ijns9040055.
2
Sickle cell diseases: What can nuclear medicine offer?镰状细胞病:核医学能提供什么?
Hell J Nucl Med. 2019 Jan-Apr;22(1):2-3. doi: 10.1967/s002449910950. Epub 2019 Mar 7.
3
Screening for sickle cell disease in newborns: a systematic review.新生儿镰状细胞病筛查:系统评价。
Syst Rev. 2020 Oct 30;9(1):250. doi: 10.1186/s13643-020-01504-5.
4
Sickle Cell Trait镰状细胞性状
5
Fifteen years of newborn sickle cell disease screening in Madrid, Spain: an emerging disease in a European country.西班牙马德里新生儿镰状细胞病筛查 15 年:一个欧洲国家的新兴疾病。
Ann Hematol. 2020 Jul;99(7):1465-1474. doi: 10.1007/s00277-020-04044-z. Epub 2020 May 26.
6
Sickle Cell Nephropathy镰状细胞肾病
7
[Neonatal screening of hemoglobinopathies and G6PD deficiency in Catalonia (Spain). Molecular study of sickle cell disease associated with alpha thalassemia and G6PD deficiency].[西班牙加泰罗尼亚地区血红蛋白病和葡萄糖-6-磷酸脱氢酶(G6PD)缺乏症的新生儿筛查。与α地中海贫血和G6PD缺乏症相关的镰状细胞病的分子研究]
Med Clin (Barc). 2007 Jun 30;129(5):161-4. doi: 10.1157/13107791.
8
Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening.德国西南部镰状细胞病的显著流行:一项出生队列研究结果表明新生儿筛查的必要性。
Ann Hematol. 2016 Feb;95(3):397-402. doi: 10.1007/s00277-015-2573-y. Epub 2015 Dec 12.
9
Hematopoietic Stem Cell Transplantation in Sickle Cell Disease镰状细胞病中的造血干细胞移植
10
Crizanlizumab in sickle cell disease.克立唑单抗治疗镰状细胞病
Pain Manag. 2023 Oct 18. doi: 10.2217/pmt-2023-0031.

引用本文的文献

1
Newborn Screening for Sickle Cell Disease in Catalonia between 2015 and 2022-Epidemiology and Impact on Clinical Events.2015年至2022年加泰罗尼亚地区镰状细胞病的新生儿筛查——流行病学及对临床事件的影响
Int J Neonatal Screen. 2024 Oct 3;10(4):69. doi: 10.3390/ijns10040069.

本文引用的文献

1
Neonatal Screening for Sickle Cell Disease in Western Andalusia: Results and Lessons Learnt after 3 Years of Implementation.安达卢西亚西部镰状细胞病的新生儿筛查:实施3年后的结果与经验教训
Am J Perinatol. 2024 May;41(S 01):e893-e900. doi: 10.1055/s-0042-1759646. Epub 2022 Dec 29.
2
Advances in the diagnosis and treatment of sickle cell disease.镰状细胞病的诊断和治疗进展。
J Hematol Oncol. 2022 Mar 3;15(1):20. doi: 10.1186/s13045-022-01237-z.
3
Utilization of Pneumococcal Vaccine and Penicillin Prophylaxis in Sickle Cell Disease in Three African Countries: Assessment among Healthcare Providers in SickleInAfrica.
在三个非洲国家中,利用肺炎球菌疫苗和青霉素预防措施治疗镰状细胞病:SickleInAfrica 中医疗保健提供者的评估。
Hemoglobin. 2021 May;45(3):163-170. doi: 10.1080/03630269.2021.1954943. Epub 2021 Aug 6.
4
Trends in Sickle Cell Disease-Related Mortality in the United States, 1979 to 2017.美国 1979 年至 2017 年镰状细胞病相关死亡率趋势。
Ann Emerg Med. 2020 Sep;76(3S):S28-S36. doi: 10.1016/j.annemergmed.2020.08.009.
5
Update of the Spanish registry of haemoglobinopathies in children and adults.西班牙儿童和成人血红蛋白病登记处的更新情况。
Med Clin (Barc). 2020 Aug 14;155(3):95-103. doi: 10.1016/j.medcli.2019.10.011. Epub 2020 Feb 26.
6
How we prevent and manage infection in sickle cell disease.如何预防和管理镰状细胞病中的感染。
Br J Haematol. 2015 Sep;170(6):757-67. doi: 10.1111/bjh.13526. Epub 2015 May 27.
7
Genetic screening: NAS recommends proceeding with caution.基因筛查:美国国家科学院建议谨慎行事。
Science. 1975 Jul 11;189(4197):119-20. doi: 10.1126/science.11643273.
8
Neonatal screening for sickle cell disease.新生儿镰状细胞病筛查
Cochrane Database Syst Rev. 2000;2000(2):CD001913. doi: 10.1002/14651858.CD001913.
9
Universal versus targeted screening of infants for sickle cell disease: a cost-effectiveness analysis.对婴儿进行镰状细胞病的普遍筛查与针对性筛查:一项成本效益分析。
J Pediatr. 2000 Feb;136(2):201-8. doi: 10.1016/s0022-3476(00)70102-8.
10
Newborn screening for sickle cell disease: 4 years of experience from California's newborn screening program.镰状细胞病的新生儿筛查:来自加利福尼亚州新生儿筛查项目的4年经验。
J Pediatr Hematol Oncol. 1996 Feb;18(1):36-41. doi: 10.1097/00043426-199602000-00007.